# Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study

> **NCT07282132** · — · NOT_YET_RECRUITING · sponsor: **Federico II University** · enrollment: 150 (estimated)

## Conditions studied

- Polycytemia Vera

## Interventions

- **DRUG:** Ropeginterferon alfa-2b (BESREMi®)

## Key facts

- **NCT ID:** NCT07282132
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-10
- **Primary completion:** 2026-03-26
- **Final completion:** 2026-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282132, "Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07282132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*